References
- Advisory Council on the Misuse of Drugs. (2015). How can opioid substitution therapy (and drug treatment and recovery systems) be ACMD Recovery Committee Optimising OST Report. Retrieved 26 June 2018 from https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/470399/ACMD_RC_OPTIMISING_OST_REPORT_231015.pdf
- Alam-Mehrjerdi, Z., Noori, R., & Dolan, K. (2014). Opioid use, treatment and harm reduction services: The first report from the Persian Gulf region. Journal of Substance Use, 1–7. doi:10.3109/14659891.2014.966344
- American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders: DSM-5 (5th ed.). Washington, D.C: American Psychiatric Pub.
- Bassiony, M. (2013). Substance use disorders in Saudi Arabia: Review article. Journal of Substance Use, 18(6), 450–466. doi:10.3109/14659891.2011.606349
- Centers for Disease Control and Prevention. (2016). Centers for Disease Control and Prevention (CDC) program guidance for implementing certain components of syringe services programs. 2016, 1–8 https://www.cdc.gov/hiv/pdf/risk/cdc-hiv-syringe-exchange-services.pdf.
- Clinical Guidelines on Drug Misuse and Dependence Update 2017 Independent Expert Working Group. (2017). Drug misuse and dependence. drug misuse and dependence: UK guidelines on clinical management. London, UK: Global and Public Health / Population Health / Healthy Behaviours / 25460.
- Dematteis, M., Auriacombe, M., D’Agnone, O., Somaini, L., Szerman, N., Littlewood, R., … Soyka, M. (2017). Recommendations for buprenorphine and methadone therapy in opioid use disorder: A European consensus. Expert Opinion on Pharmacotherapy. doi:10.1080/14656566.2017.1409722
- Elkashef, A., Zoubeidi, T., Thomas, R. A., Al, H. H., Lee, A. J., Aw, T., … Emirates, A. (2013). A profile of patients with substance use disorders and treatment outcomes : A 10-year retrospective study from the National Rehabilitation Center. International Journal of Prevention and Treatment of Substance Use Disorders, 62–75. doi:10.4038/ijptsud.v1i1.5912
- Ghaferi, H. A., Al Ali, A. Y., Gawad, T. A., & Wanigaratne, S. (2017). Developing substance misuse services in United Arab emirates : The national rehabilitation centre experience. BJPsych International, 14(4), 92–96. doi:10.1192/S2056474000002105
- Harm Reduction International. (2016). The global state of harm reduction 2016. London, UK: Harm Reduction International. Retrieved from https://doi.org/ISBN: 978-0-9935434-3-2
- Himmich, H., & Madani, N. (2016). The state of harm reduction in the Middle East and North Africa: A focus on Iran and Morocco. International Journal of Drug Policy, 31, 184–189. doi:10.1016/j.drugpo.2016.02.013
- Kampman, K., & Jarvis, M. (2015). American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use. Journal of Addiction Medicine, 9(5), 358–367. doi:10.1097/ADM.0000000000000166
- MENAHRA. (2012). Oman. Retrieved from http://www.menahra.org/en/oman
- MENAHRA. (2012a). Bahrain. Retrieved 26 June 2018 from http://www.menahra.org/en/bahrain
- MENAHRA. (2012b). Egypt. Retrieved 26 June 2018 from http://www.menahra.org/en/egypt
- MENAHRA. (2017a). Harm reduction in MENA where do we stand? Retrieved from http://www.menahra.org/images/latest-reports/Menahra_WhereDoWeStand-infographic_050917_web.pdf
- MENAHRA. (2017b). Policy brief for law enforcement officials on provision of harm reduction services.Retrieved 26 June 2018 from http://www.menahra.org/images/pdf/Policy-brief_lawenforcement_.pdf
- Oraby, D. (2013). Harm reduction approach in Egypt: The insight of injecting drug users. Harm Reduction Journal, 10, 1. doi:10.1186/1477-7517-10-17
- Sweileh, W. M., Zyoud, S. H., Al-Jabi, S. W., & Sawalha, A. F. (2014). Substance use disorders in Arab countries: Research activity and bibliometric analysis. Substance Abuse Treatment, Prevention, and Policy, 9, 33. doi:10.1186/1747-597X-9-33
- UNAIDS. (2014). UNGASS Country Progress Report. Kingdom of Bahrain. Retrieved 26 June 2018 from http://www.unaids.org/sites/default/files/country/documents//BHR_narrative_report_2014.pdf
- UNAIDS. (2015). Global AIDS Response. Country Progress Report State of Kuwait. Retrieved 26 June 2018 from http://www.unaids.org/sites/default/files/country/documents/KWT_narrative_report_2015.pdf
- United Nation’s Office on Drugs and Crime. (2015). Feasibility study: Opioid substitution treatment in Egypt. Retrieved from https://www.unodc.org/documents/middleeastandnorthafrica/drug-prevention-health-publications/OST_Feasibility_Study_in_Egypt.pdf
- World Health Organization, D. of H. (2007). Guide to starting and managing needle and syringe programmes, 64. Retrieved from https://doi.org/978 92 4 159627 5
- World Health Organization, United Nations Office on Drugs and Crime, & Joint United Nations Programme on HIV/AIDS. (2004). Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention. Position Paper, 1–33. Retrieved 26 June 2018 from http://apps.who.int/iris/bitstream/handle/10665/42848/9241591153_eng.pdf?sequence=1&isAllowed=y&ua=1
- World Health Organization. Regional Office for the Eastern Mediterranean. (2012). MENAHRA – The Middle East and North Africa Harm reduction association. Best practices in strengthening civil society’s role in delivering harm reduction services. Retrieved from http://applications.emro.who.int/dsaf/EMRPUB_2012_879.pdf